Cargando…

Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis

Despite recent advances in tuberculosis (TB) drug development and availability, successful antibiotic treatment is challenged by the parallel development of antimicrobial resistance. As a result, new approaches toward improving TB treatment have been proposed in an attempt to reduce the high TB morb...

Descripción completa

Detalles Bibliográficos
Autores principales:	du Plessis, Nelita, Kotze, Leigh A., Leukes, Vinzeigh, Walzl, Gerhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160538/ https://www.ncbi.nlm.nih.gov/pubmed/30298121 http://dx.doi.org/10.3389/fcimb.2018.00332

Ejemplares similares

Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis
por: Leukes, Vinzeigh, et al.
Publicado: (2020)

Mycobacterium tuberculosis and myeloid-derived suppressor cells: Insights into caveolin rich lipid rafts
por: Kotzé, Leigh A., et al.
Publicado: (2020)

Targeting of myeloid-derived suppressor cells by all-trans retinoic acid as host-directed therapy for human tuberculosis
por: Leukes, Vinzeigh N., et al.
Publicado: (2021)

Sildenafil, a Type-5 Phosphodiesterase Inhibitor, Fails to Reverse Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression in Cells Isolated From Tuberculosis Patients
por: Leukes, Vinzeigh N., et al.
Publicado: (2022)

Immunometabolism of Myeloid-Derived Suppressor Cells: Implications for Mycobacterium tuberculosis Infection and Insights from Tumor Biology
por: Munansangu, Brian S. M., et al.
Publicado: (2022)

Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy
por: Beltran, Caroline G. G., et al.
Publicado: (2020)

Caveolin-1 Controls Vesicular TLR2 Expression, p38 Signaling and T Cell Suppression in BCG Infected Murine Monocytic Myeloid-Derived Suppressor Cells
por: John, Vini, et al.
Publicado: (2019)

Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection
por: Shaw, Jane Alexandra, et al.
Publicado: (2023)

Culture filtrate supplementation can be used to improve Mycobacterium tuberculosis culture positivity for spinal tuberculosis diagnosis
por: Beltran, Caroline G. G., et al.
Publicado: (2022)

Regulatory Mechanisms of Autophagy-Targeted Antimicrobial Therapeutics Against Mycobacterial Infection
por: Silwal, Prashanta, et al.
Publicado: (2021)

Targeted Gene Expression Profiling of Human Myeloid Cells From Blood and Lung Compartments of Patients With Tuberculosis and Other Lung Diseases
por: Kotze, Leigh Ann, et al.
Publicado: (2022)

Long Noncoding RNA: Regulatory Mechanisms and Therapeutic Potential in Sepsis
por: Wang, Wei, et al.
Publicado: (2021)

Monocytic myeloid‐derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase‐2 inhibitors
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020)

Infection of Monocytes From Tuberculosis Patients With Two Virulent Clinical Isolates of Mycobacterium tuberculosis Induces Alterations in Myeloid Effector Functions
por: Lavalett, Lelia, et al.
Publicado: (2020)

Vitamin in the Crosshairs: Targeting Pantothenate and Coenzyme A Biosynthesis for New Antituberculosis Agents
por: Butman, Hailey S., et al.
Publicado: (2020)

Myeloid C-Type Lectin Receptors in Tuberculosis and HIV Immunity: Insights Into Co-infection?
por: Naqvi, Kubra F., et al.
Publicado: (2020)

The Iron Response of Mycobacterium tuberculosis and Its Implications for Tuberculosis Pathogenesis and Novel Therapeutics
por: Rodriguez, G. Marcela, et al.
Publicado: (2022)

Aptamers: An Emerging Tool for Diagnosis and Therapeutics in Tuberculosis
por: Srivastava, Shruti, et al.
Publicado: (2021)

The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis
por: Magcwebeba, Tandeka, et al.
Publicado: (2019)

Role of Tau protein in long COVID and potential therapeutic targets
por: Marwaha, Bharat
Publicado: (2023)

Corrigendum: The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis
por: Magcwebeba, Tandeka, et al.
Publicado: (2019)

Human Monocytic Suppressive Cells Promote Replication of Mycobacterium tuberculosis and Alter Stability of in vitro Generated Granulomas
por: Agrawal, Neha, et al.
Publicado: (2018)

Circulating Monocyte-Like Myeloid Derived Suppressor Cells and CD16 Positive Monocytes Correlate With Immunological Responsiveness of Tuberculosis Patients
por: Amiano, Nicolás O., et al.
Publicado: (2022)

Lactate Dehydrogenase as a Potential Therapeutic Drug Target to Control Babesia bigemina
por: He, Lan, et al.
Publicado: (2022)

Ex vivo and in vivo evidence that cigarette smoke-exposed T regulatory cells impair host immunity against Mycobacterium tuberculosis
por: Bai, Xiyuan, et al.
Publicado: (2023)

Editorial: The regulatory immune system as a target to improve adjuvants and novel vaccines
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2023)

The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
por: Eribo, Osagie A., et al.
Publicado: (2019)

Autophagy Is a Potential Therapeutic Target Against Duck Tembusu Virus Infection in vivo
por: Hu, Zhiqiang, et al.
Publicado: (2020)

Ferroptosis in COVID-19-related liver injury: A potential mechanism and therapeutic target
por: Chen, Yunqing, et al.
Publicado: (2022)

The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
por: Zhang, Yu-Lin, et al.
Publicado: (2022)

Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets
por: Oh, Sangmi, et al.
Publicado: (2021)

Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
por: Greenstein, Talia, et al.
Publicado: (2023)

Corrigendum: Autophagy Is a Potential Therapeutic Target Against Duck Tembusu Virus Infection in Vivo
por: Hu, Zhiqiang, et al.
Publicado: (2021)

Targeting Myeloid-Derived Suppressor Cells to Enhance a Trans-Sialidase-Based Vaccine Against Trypanosoma cruzi
por: Gamba, Juan Cruz, et al.
Publicado: (2021)

Host Cell Targets of Released Lipid and Secreted Protein Effectors of Mycobacterium tuberculosis
por: Augenstreich, Jacques, et al.
Publicado: (2020)

Comprehensive Determination of Mycobacterium tuberculosis and Nontuberculous Mycobacteria From Targeted Capture Sequencing
por: He, Ya, et al.
Publicado: (2020)

Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches
por: Singh, Vinayak
Publicado: (2021)

Integrins as Therapeutic Targets for SARS-CoV-2
por: Gressett, Timothy E., et al.
Publicado: (2022)

Editorial: Quorum-sensing in Gram-positive pathogens – mechanisms, role in infection, and potential as a therapeutic target
por: Otto, Michael, et al.
Publicado: (2023)

Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis
por: McNeil, Matthew B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5oarqjlus2qi9r656cu05q7hnc